Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis.

[1]  D. Scheinert,et al.  Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial , 2022, CardioVascular and Interventional Radiology.

[2]  S. Holewijn,et al.  Cost-Effectiveness of Urea Excipient-Based Drug-Coated Balloons for Chronic Limb-Threatening Ischemia from Femoropopliteal Disease in the Netherlands and Germany , 2022, CardioVascular and Interventional Radiology.

[3]  T. Walker,et al.  Insulin-Dependent Status Influences Post-Procedural Outcomes in Diabetic Patients Following Lower Extremity Endovascular Intervention for Peripheral Arterial Disease , 2021, CardioVascular and Interventional Radiology.

[4]  M. Brodmann,et al.  Twenty-four-month outcomes of drug-coated balloon in diabetic patients in the BIOLUX P-III registry: a subgroup analysis. , 2021, Annals of vascular surgery.

[5]  Shenming Wang,et al.  Long-Term Safety and Efficacy of Angioplasty of Femoropopliteal Artery Disease with Drug-Coated Balloons from the AcoArt I Trial. , 2021, Journal of vascular surgery.

[6]  M. Brodmann,et al.  Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry , 2020, CardioVascular and Interventional Radiology.

[7]  S. Saito,et al.  Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty , 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[8]  F. Vermassen,et al.  Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort , 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[9]  W. Guo,et al.  IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population , 2019, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[10]  John V. White,et al.  Global vascular guidelines on the management of chronic limb-threatening ischemia. , 2019, Journal of vascular surgery.

[11]  S. Holewijn,et al.  Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study , 2019, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[12]  Hong Wang,et al.  Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study. , 2018, JACC. Cardiovascular interventions.

[13]  L. Miller,et al.  Disease Burden and Clinical Outcomes Following Initial Diagnosis of Critical Limb Ischemia in the Medicare Population. , 2018, JACC. Cardiovascular interventions.

[14]  F. Vermassen,et al.  Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  R. Guzman,et al.  Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease. , 2017, Journal of vascular surgery.

[16]  C. Paetzel,et al.  The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. , 2017, JACC. Cardiovascular interventions.

[17]  M. Milošević,et al.  Impact of diabetes on mortality in peripheral artery disease: a meta‐analysis , 2017, Clinical cardiology.

[18]  R. G. Statius van Eps,et al.  Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials , 2016, Diabetes Care.

[19]  W. Guo,et al.  Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial. , 2016, JACC. Cardiovascular interventions.

[20]  E. Armstrong,et al.  Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. , 2015, World journal of diabetes.

[21]  D. Scheinert,et al.  Paclitaxel-Releasing Balloon in Femoropopliteal Lesions Using a BTHC Excipient , 2015, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[22]  T. Mueller,et al.  Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. , 2014, Journal of vascular surgery.

[23]  G. LaMuraglia,et al.  Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. , 2009, Journal of vascular surgery.

[24]  M. Bischof,et al.  Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease , 2007, European journal of clinical investigation.

[25]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[26]  C. Claussen,et al.  Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. , 2015, JACC. Cardiovascular interventions.